These incretin effects explain the initially surprising weight loss observed in the treatment groups of the cardiovascular trials, with subjects taking GLP-1/GIP agonists losing from 3% to 12% of their body weight
alli can help just over 46% of people achieve at least a 5% body weight loss in 6 months, while with Mounjaro, 96.3% achieve the same loss after 72 weeks
Sermorelin supports fat loss indirectly by improving sleep quality, recovery, and overall hormonal balance
Ozempic has been approved for diabetes, though it's sometimes still used for weight loss
Once all water is added, swirl the vial gently in a circular motion
GLP1 medications do more than support weight lossthey can play a meaningful role in heart health, blood sugar control and even sleep quality